peptide acylation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-08-19. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Peptide backbone with a fatty diacid chain |
| Molecular weight | About 4813 Da | Calculated from the formula |
| Receptor targets | GIP and GLP-1 receptors | Dual agonist activity at both sites |
| Route of administration | Subcutaneous injection | No approved oral form at present |
| Elimination half-life | About 5 days | Supports extended intervals between administrations |
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
leveling effect The effect of a solvent on the chemical properties of acids or bases which are dissolved in the solvent. The strength of a strong acid is limited or "leveled" by the basicity of the solvent, and likewise the strength of a strong base is limited by the acidity of the solvent, such that the effective pH of the solution is higher or lower than might be suggested by the acid's or base's dissociation constant.
25 June – Astronomers report the discovery and confirmation of two unusually low-density exoplanets, TOI-791 b and TOI-791 c, orbiting the star TOI-791 about 1,113 light-years from Earth. Detected using NASA's Transiting Exoplanet Survey Satellite, the Jupiter-sized "super-puff" planets have densities of 0.038 and 0.047 g/cm3, respectively, making them among the lowest-density giant planets known and the largest planets yet found with densities below 0.05 g/cm3. 29 June – Palaeontologists identify a fossil vertebra collected on James Ross Island in 1985 as the earliest-known dinosaur bone collected in Antarctica. The specimen, stored for 40 years in the British Antarctic Survey collections, is confirmed to be a tail bone from a titanosaur, a group of long-necked sauropod dinosaurs. The animal is estimated to have lived about 82 million years ago, during the Late Cretaceous, when Antarctica was covered in forest. 30 June – Astronomers report a revised orbit and mass for the nearby habitable zone super-Earth GJ 3378 b. Combining radial velocity data from the Habitable-zone Planet Finder, NEID, CARMENES and SPIRou spectrometers, the team finds that the planet has an orbital period of 21.45 days and a minimum mass of 2.3 Earth masses, rather than earlier estimates of 24.73 days and 5.26 Earth masses. The revision leaves the planet within the conservative liquid-water habitable zone of its red dwarf host star, increases the likelihood that it has a terrestrial composition, and suggests that it may have retained an atmosphere despite high X-ray and ultraviolet exposure.
The main step of the process is the negative selection of newly generated trypsin peptides using a specialized polymer. The polymer ignores the unreactive primary amines blocked by their tags, allowing them to be separated from trypsin generated peptides by ultrafiltration for Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) analysis. These mature and neo-N-termini will differ in ratios between the protease treated versus untreated samples and make up the proteolytic fingerprint of a protease. TAILS is also compatible with Stable isotope labeling by amino acids in cell culture (SILAC). COFRADIC was the earliest technique to capitalize on negative selection to enrich for protein N-termini. Sample proteins are first blocked by reduction and alkylation at their primary amines before endopeptidase treatment. Its negative selection method relies on strong cation exchange chromatography (SCX) to enrich for peptides representing N- and C-termini of proteins based on differences in peptide charge and pH. Additional orthogonal chromatography treatments change the biochemical character of the peptides for further enrichment before final LC-MS/MS analysis. Groups have continued to adapt and improve this technology for protease-substrate discovery. C-terminomics has always been complicated due to the chemical nature of its targets. Carboxyl groups are less reactive than primary amines, making C-terminomic techniques more complex than established N-terminomic approaches.
In early May 1990, one of the two A&M researchers, Kevin Wolf, acknowledged the possibility of spiking, but said that the most likely explanation was tritium contamination in the palladium electrodes or simply contamination due to sloppy work. In June 1990 an article in Science by science writer Gary Taubes destroyed the public credibility of the A&M tritium results when it accused its group leader John Bockris and one of his graduate students of spiking the cells with tritium. In October 1990 Wolf finally said that the results were explained by tritium contamination in the rods. An A&M cold fusion review panel found that the tritium evidence was not convincing and that, while they couldn't rule out spiking, contamination and measurements problems were more likely explanations, and Bockris never got support from his faculty to resume his research. On 30 June 1991, the National Cold Fusion Institute closed after it ran out of funds; it found no excess heat, and its reports of tritium production were met with indifference. On 1 January 1991, Pons left the University of Utah and went to Europe. In 1992, Pons and Fleischmann resumed research with Toyota's IMRA lab in France. Fleischmann left for England in 1995, and the contract with Pons was not renewed in 1998 after spending $40 million with no tangible results. The IMRA laboratory stopped cold fusion research in 1998 after spending £12 million. Pons has made no public declarations since, and only Fleischmann continued giving talks and publishing papers.
Sources: en.wikipedia.org
=== Mapping from A1c to estimated average glucose === The approximate mapping between HbA1c values given in DCCT percentage (%) and eAG (estimated average glucose) measurements is given by the following equation:
==== Sigma bond cleavage / σ-cleavage ==== Sigma bond cleavage is most commonly observed in molecules that can produce stable cations, such as saturated alkanes or secondary and tertiary carbocations. This occurs when an alpha electron is removed. The C-C bond elongates and weakens causing fragmentation. Fragmentation at this site produces a charged and a radical fragment.
This consists of a refrigeration cycle, where heat is removed from a low-temperature space or source and rejected to a high-temperature sink with the help of external work, inverse of the thermodynamic power cycle. In the power cycle, heat is supplied from a high-temperature source to the engine, part of the heat being used to produce work and the rest being rejected to a low-temperature sink. This satisfies the second law of thermodynamics. A refrigeration cycle describes the changes that take place in the refrigerant as it alternately absorbs and rejects heat as it circulates through a refrigerator. It is also applied to heating, ventilation, and air conditioning HVACR work, when describing the "process" of refrigerant flow through an HVACR unit, whether it is a packaged or split system. Heat naturally flows from hot to cold. Work is applied to cool a living space or storage volume by pumping heat from a lower temperature heat source into a higher temperature heat sink. Insulation is used to reduce the work and energy needed to achieve and maintain a lower temperature in the cooled space. The operating principle of the refrigeration cycle was described mathematically by Sadi Carnot in 1824 as a heat engine. The most common types of refrigeration systems use the reverse-Rankine vapor-compression refrigeration cycle, although absorption heat pumps are used in a minority of applications. Cyclic refrigeration can be classified as:
=== Powdered egg whites === Egg white can be dried alone for better foaming. The result is egg white powder. The ingredient called egg white protein is virtually identical to egg white powder, as no additional step is employed to separate the protein in egg white from other components before drying. Dried egg white products often have their foaming ability compromised by the inadvertent inclusion of egg yolk. Adding phospholipase A2 appears to break down the contaminant and restore the foaming power.
As a result of the COVID-19 pandemic, biosecurity measures have become a highly visible aspect of border control across the globe. Most notably, quarantine and mandatory COVID-19 vaccination for international travelers. Together with a decreased willingness to travel, the implementation of biosecurity measures has had a negative economic and social impact on the travel industry. Slow travel gained popularity during the pandemic, with tourists visiting fewer destinations on their trips. Biosecurity measures such as restrictions on cross-border travel, the introduction of mandatory vaccination for international travellers, and the adoption of quarantine or mandatory testing measures have helped to contain the spread of COVID-19. While test-based border screening measures may prove effective under certain circumstances, they may fail to detect a significant quantity of positive cases if only conducted upon arrival without follow-up. A minimum 10-day quarantine may help prevent the spread of COVID-19 and may be more effective when combined with additional control measures, such as border screening. A study in Science found that travel restrictions could delay the initial arrival of COVID-19 in a country, but that they produced only modest overall effects unless combined with domestic infection prevention and control measures to reduce transmissions considerably. (That is consistent with prior research on influenza and other communicable diseases.) Travel bans early in the pandemic were most effective for isolated locations, such as small island nations.
Sources: en.wikipedia.org
It is a synthetic 39-amino-acid peptide that acts on two incretin receptors, the GIP receptor and the GLP-1 receptor. It is given by subcutaneous injection and has a circulating half-life of roughly five days. It is not a small molecule and is not absorbed usefully from the gut in conventional oral form.
Selective agents act on one receptor, while tirzepatide engages both GIP and GLP-1 receptors. The added GIP activity may contribute effects on insulin sensitivity and on fat metabolism. Whether the dual action produces meaningful clinical advantages beyond differences in potency is still being examined.
The downstream consequences of GIP receptor activation are not fully characterised in humans. It is also unclear how much each receptor contributes to appetite reduction and to shifts in body composition. Published work describes associations and proposed pathways rather than settled causal chains.
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.